Doctor Victoria Orshanskaya
Almazov National Medical Research Centre, Saint Petersburg (Russian Federation)
Member of:
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Histomolecular fibrotic profile and an extent of the atrial and ventricular electroanatomical substrate in patients with atrial fibrillation and heart failure
Event: ESC Congress 2020
Topic: Heart Failure in Atrial Fibrillation
Session: Atrial Fibrillation ePosters
Personalized interventional strategy in patients with long-standing persistent atrial fibrillation and chronic heart failure
Event: EHRA 2019
Topic: Rhythm Control, Catheter Ablation
Session: Rapid Fire 1: atrial fibrillation ablation: alternatives to improve success
Personalized ablation strategy in patients with long-standing persistent atrial fibrillation and chronic heart failure.
Event: ESC Congress 2018
Topic: Rhythm Control, Catheter Ablation
Session: Atrial fibrillation - Ablation
Association between an extent of electroanatomical substrate, circulating pro-fibrotic biomarkers and myocardial tissue morphology in patients with atrial fibrillation and heart failure.
Event: EHRA 2018
Topic: Heart Failure in Atrial Fibrillation
Session: Atrial fibrillation - Clinical
Relationship between an extent of electroanatomical substrate, serum pro-fibrotic biomarkers and histopathological data in patients with atrial fibrillation and heart failure.
Event: ESC Congress 2017
Topic: Atrial fibrillation (AF)
Session: Stroke prevention
Relationship of the extent of left atrial electroanatomical substrate and risk of thromboembolic events in patients with atrial fibrillation.
Event: ESC Congress 2016
Topic: Atrial fibrillation (AF)
Session: Best Posters in risk assessment of thromboembolic events in atrial fibrillation
ESC 365 is supported by
